Skip to main content

Reptile Metabolic Bone Disease: Diagnosis, Treatment, and Husbandry Correction

PublishedJuly 7, 2026Reading time12 minExoticRx Editorial

Editorially reviewed against published veterinary references. Awaiting credentialed clinical reviewer — our editorial process.

Clinical relevance

Nutritional secondary hyperparathyroidism (NSHP), almost universally referred to in clinical shorthand as metabolic bone disease (MBD), remains the single most common nutritional disorder of captive reptiles presenting to general and exotic-animal practitioners. Despite decades of educational effort, husbandry failure in pet-trade species continues to drive a steady caseload of juvenile bearded dragons (Pogona vitticeps), green iguanas (Iguana iguana), panther and veiled chameleons (Furcifer pardalis, Chamaeleo calyptratus), leopard geckos (Eublepharis macularius), and juvenile chelonians presenting with hindlimb paresis, pathologic fractures, or tetany.

For the primary-care clinician, MBD matters for three reasons. First, the diagnosis is frequently missed or delayed because owners attribute early signs to "normal" growth abnormalities. Second, severe hypocalcemic tetany is a true emergency requiring immediate parenteral calcium and a different stabilization mindset than mammalian hypocalcemia. Third, durable resolution is impossible without correcting the husbandry substrate; pharmacologic management without environmental intervention produces relapse.

This article focuses on diagnostic workup, parenteral and oral therapy, and the husbandry parameters that must change for recovery. It complements ExoticRx species-specific dosing guides for bearded dragons and ball pythons rather than replacing them.

Pathophysiology and risk factors

NSHP develops when the calcium:phosphorus (Ca:P) ratio of absorbable dietary calcium falls chronically below the species requirement, when ultraviolet B (UVB)-driven cutaneous synthesis of cholecalciferol is inadequate to allow intestinal calcium absorption, or both. The resulting drop in ionized calcium drives parathyroid hormone (PTH) secretion, osteoclastic resorption of cortical and trabecular bone, and replacement of mineralized matrix with fibrous tissue (fibrous osteodystrophy). Mader and Divers describe the cascade in detail in Reptile Medicine and Surgery, 3rd edition.

The contributing risk factors converge on husbandry:

Clinical signs and presentation

Presenting signs reflect the affected skeletal regions and the severity of ionized hypocalcemia.

Diagnostic workup

A focused workup is usually sufficient in primary practice.

  1. History. Ask specifically about UVB bulb type, age of bulb, basking distance, ambient and basking temperatures, dietary items, and supplementation frequency. Owners frequently misreport "I have a UVB bulb" when the bulb is a coil compact or is more than 12 months old.
  2. Physical examination. Palpate long bones for pliability and crepitus; palpate the mandible and maxilla for "rubber jaw"; assess spinal alignment, gait, and cloacal tone.
  3. Whole-body radiographs. Two orthogonal views demonstrate decreased cortical opacity, cortical thinning, loss of corticomedullary distinction, folding fractures, and vertebral compression. Comparison with reference images in Mader is helpful for less experienced readers. Radiographic changes lag biochemical disease and lag recovery.
  4. Biochemistry. Total calcium is unreliable because of binding-protein and albumin variation. Ionized calcium is the preferred analyte. Reported reference values include approximately 1.47 ± 0.11 mmol/L in healthy green iguanas (Dennis et al., AJVR, 2001) and a median near 1.34 mmol/L (range 1.22–1.46) in bearded dragons. Ionized calcium <1.0 mmol/L is consistent with clinically significant hypocalcemia. Phosphorus is typically elevated; an inverted Ca:P ratio supports the diagnosis.
  5. PTH. Reptile-validated PTH assays are not widely available; specialist laboratories may run mammalian intact-PTH assays with caution. PTH is rarely required to make the diagnosis.
  6. Differentials. Renal secondary hyperparathyroidism (especially older iguanas), trauma without underlying MBD, septic osteomyelitis, neoplasia, and hypovitaminosis A in chelonians.

Initial stabilization

The unstable MBD reptile is typically dehydrated, hypothermic, anorexic, and either tetanic or recumbent with pathologic fractures. Stabilize in this order:

  1. Restore POTZ. A reptile below its species POTZ will not metabolize drugs, absorb fluids, or mineralize bone. Place the patient in a pre-warmed enclosure or incubator at species-appropriate ambient temperature (commonly 28–32 °C for most pet-trade lizards) before any other intervention.
  2. Fluid therapy. Warm isotonic crystalloid (lactated Ringer's or Plasma-Lyte A) at 15–25 mL/kg/day SC, intracoelomic, or via intraosseous catheter in collapsed patients. Reptile-formulated balanced solutions (e.g., reptile Ringer's, a 2:1 or 1:1 mix of LRS and 2.5% dextrose-saline) may be used per clinician preference; see Mader and Divers for detailed regimens.
  3. Parenteral calcium for tetany or symptomatic hypocalcemia. See dosing table below.
  4. Analgesia for fractures. Meloxicam is the most commonly used reptile NSAID; see dosing table below. Opioids may be added per clinician preference for severe pain (tramadol and hydromorphone protocols are reviewed in Carpenter's Exotic Animal Formulary).
  5. Critical care nutrition. Once normothermic and rehydrated, deliver a species-appropriate critical care diet (Oxbow Carnivore Care or Herbivore Care, Emeraid Intensive Care Carnivore/Omnivore/Herbivore) by syringe or pharyngostomy tube at 1–3% body weight per feeding, titrated to gut transit.
  6. Stabilize fractures conservatively. Most pathologic long-bone fractures in MBD heal best with cage rest, padded splinting, and mineralization rather than internal fixation; demineralized bone holds implants poorly.

Parenteral calcium dosing for stabilization

DrugIndicationRouteDoseFrequencyCitationEvidence level
Calcium gluconate 10%Acute tetany / severe symptomatic hypocalcemiaIV or IO, slow50–100 mg/kg, diluted, given slowly with cardiac monitoringOnce; repeat based on ionized calciumCarpenter, Exotic Animal Formulary, 5th ed.; Mader & Divers, Reptile Medicine and Surgery, 3rd ed.Expert consensus / extrapolated
Calcium gluconate 10%Symptomatic hypocalcemia, no IV accessIM or SC (dilute; rotate sites; tissue-irritating)100 mg/kgq6–12h until stableCarpenter, 5th ed.Expert consensus
Calcium gluconate 10%Maintenance during fluid therapyAdded to crystalloid bag100–200 mg/kg/day CRI equivalentContinuous infusionMader & Divers, 3rd ed.Expert consensus
MeloxicamAnalgesia for fractures and fibrous osteodystrophyPO, SC, IM0.2 mg/kg (most species); 0.4 mg/kg has analgesic evidence in bearded dragonsq24hCarpenter, 5th ed.; bearded dragon analgesia studies (Olesen et al., 2008; Divers et al.)Limited PK; expert consensus

Calcium gluconate is irritating to soft tissue; dilute when possible, rotate injection sites, and avoid intracardiac or rapid IV bolus administration. Monitor for bradyarrhythmia during IV administration. Meloxicam in reptiles has limited pharmacokinetic data; use the lowest effective dose, ensure hydration, and avoid prolonged courses in patients with renal compromise.

Calcium and vitamin D supplementation

Once the patient is normothermic, hydrated, and out of acute tetany, transition to oral supplementation as soon as the gastrointestinal tract is functional. Re-mineralization is an outpatient project measured in weeks to months.

DrugIndicationRouteDoseFrequencyCitationEvidence level
Calcium glubionate (Neocalglucon, 23 mg elemental Ca/mL)Oral repletion in stabilized patientPO23–46 mg elemental Ca/kg (≈1–2 mL/kg of 23 mg/mL syrup)q12–24h × 30 days, then taperCarpenter, Exotic Animal Formulary, 5th ed.; BSAVA Manual of Reptiles, 3rd ed.Expert consensus
Calcium carbonate (powder, dietary)Long-term dietary fortificationPO, dusted on prey or saladLight dust at every feeding (juvenile insectivores), 2–3×/week (adult)IndefiniteMader & Divers, 3rd ed.Expert consensus
Cholecalciferol (vitamin D3, oral combined Ca/D3 supplement)Adjunct in confirmed D3 deficiency where UVB cannot be optimized immediatelyPOPer manufacturer label of reptile-formulated Ca/D3 product (e.g., Repashy Calcium Plus, Zoo Med ReptiVite with D3)1–3×/week per speciesMader & Divers, 3rd ed.; BSAVA Manual of ReptilesExpert consensus
Calcitriol (1,25-(OH)2-D3)Refractory hypocalcemia not responding to calcium and UVBPO0.02–0.03 µg/kg q24–48h, short course only, with ionized calcium monitoringLimited courseCarpenter, 5th ed.Limited; specialist use
Calcitonin (salmon)Adjunct after ionized calcium has normalized, to drive calcium back into boneSC or IM50 IU/kgq7d × 1–2 dosesMader & Divers, 3rd ed.; Carpenter, 5th ed.Controversial; expert opinion

Cautions.

Husbandry correction

Pharmacology buys the patient time. Husbandry correction is the cure. Coach the owner through each item before discharge and verify at the recheck.

Long-term monitoring and recovery

Schedule rechecks at 2 weeks, 4 weeks, then monthly until biochemical and radiographic resolution.

When to refer

Refer to a board-certified reptile or zoological-medicine specialist (ABVP-Reptile and Amphibian, ECZM-Herpetology, ACZM) when:

Key references


Disclaimer: This article is intended for licensed veterinarians and veterinary professionals. Drug doses, protocols, and clinical recommendations are summarized from cited primary sources but require clinical judgment, species-specific consideration, and verification against current product labeling and the most recent edition of the source text. ExoticRx does not provide veterinary advice to pet owners and is not a substitute for hands-on examination by a licensed veterinarian.